Sin conexión a internet: se muestra la versión guardada de la página.

Fennec Pharmaceut…

USUSD
← Al Screener
US:FENCTO:FRX

Fennec Pharmaceuticals Inc (TO:FRX) — Biotechnology: Biological Products (No Diagnostic Substances). Número de bolsas en las que cotizan las acciones de la empresa: 2. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

Sobre la Empresa

Sitio Web
fennecpharma.com
Relaciones con los Inversores
investors.fennecpharma.com/
Sector
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede Central
RESEARCH TRIANGLE PARK, United States
Gestión
Jeffrey S. Hackman
Últimos Informes
trimestral 2026 · 10-Q for the period ended 2026-03-31
Empleados
35
Cotiza Desde
12.06.2001 (TO:FRX)
Acciones en Circulación
35.07 M a 2026-08-11
Capital Flotante
19.88 M
Capitalización Bursátil
375.57 M USD
Insiders
14.13%
Inversores Institucionales
54.24%
Industria (SIC)
Biological Products, (No Diagnostic Substances)
P/E
pérdidas
P/B
8.38
FCF
3.92 M USD
Deuda
19.4 M USD
caja neta
Resultados y FCF — para los 12 meses hasta 30.06.2026 (el último informe de la empresa).
NAV
1.21 USD · P/NAV 8.65
Fecha del Balance30.06.2026
Activos75.8 M USD
− Pasivos33.3 M USD
= NAV (patrimonio de los accionistas de la empresa)42.4 M USD
= NAV Tangible42.4 M USD
Acciones35 034 000
NAV por Acción1.21 USD
NAV Tangible por Acción1.21 USD
Precio de la Acción (FRX)14.9100 CAD
P/NAV8.65
Historial del NAV
Fecha del BalanceNAVNAV por Acción
30.06.202642.4 M USD1.21 USD
31.03.202637.7 M USD1.09 USD
31.12.202535.5 M USD1.04 USD
30.09.2025−4.49 M USD−0.16 USD
30.06.2025−7.46 M USD−0.27 USD
31.03.2025−5.88 M USD−0.21 USD
31.12.2024−5.87 M USD−0.21 USD
30.09.2024−5.17 M USD−0.19 USD
Descripción

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksFENC principalUSD10.15 +0.69%acciones ordinarias
TO Toronto Stock ExchangeFRX secundariaCAD14.91 +4.63%acciones ordinarias

Precio en 3 Meses

día alcista día bajistaPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Rosalind Advisors, Inc.9.07%3.19 M2026-06-30
AIGH Capital Management…7.07%2.49 M2026-06-30
Solas Capital Management…5.38%1.89 M2026-06-30
Blackrock Inc.4.92%1.73 M2026-06-30
AWM Investment Company,…3.3%1.16 M2026-06-30
Vanguard Capital Managem…2.39%839 3062026-06-30
VANGUARD INDEX FUNDS-Van…2.32%815 1922026-06-30
iShares Trust-iShares Ru…2.11%742 1942026-08-31
Prospect Capital Advisor…1.42%497 8002026-06-30
State Street Corporation1.21%426 0042026-06-30
Geode Capital Management…1.15%402 5662026-06-30
Fidelity Salem Street Tr…0.9%316 4712026-07-31
iShares Trust-iShares Ru…0.78%274 7812026-08-31
ANDRADE ROBERT C (Chief…≈0.69%241 3062026-08-31
Jane Street Group, LLC0.67%233 8772026-06-30
VANGUARD SCOTTSDALE FUND…0.42%149 1562026-05-31
RAYKOV ROSTISLAV CHRISTO…≈0.35%124 4112026-09-01
Bridgeway Funds, Inc.-Ul…0.31%108 0052026-06-30
iShares Trust-iShares Mi…0.28%98 2942026-08-31
College Retirement Equit…0.24%85 1242026-06-30
SCHWAB CAPITAL TRUST-Sch…0.2%70 5042026-07-31
HACKMAN JEFFREY S (Chief…≈0.19%67 4612026-09-30
RALLIS CHRISTOPHER ANIGE…≈0.18%63 0772026-05-11
Quantitative Master Seri…0.14%50 4812026-06-30
CIOFFI CHRISTIANA MARIE…≈0.07%24 6442026-08-31
EVANS TERRY L (Officer)≈0.06%21 6872026-09-30
SAYAD PIERRE SARGIS PH.D…≈0.03%9 6872026-09-30
BRUGHERA MARCO MARIA (Di…—02026-09-15
SOUTHPOINT CAPITAL ADVIS…——2025-12-24